Diabetic Macular Edema Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALIM | D | Alimera Sciences, Inc. | -0.30 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 0.00 | |
EPRX | C | Eupraxia Pharmaceuticals Inc. | 1.02 | |
EYPT | F | EyePoint Pharmaceuticals, Inc. | 3.94 | |
KALV | C | KalVista Pharmaceuticals, Inc. | -3.84 | |
OCS | C | Oculis Holding AG | -1.23 | |
OCUP | F | Ocuphire Pharma, Inc. | 1.76 | |
OPT | C | Opthea Limited | -0.83 | |
RZLT | B | Rezolute, Inc. | -1.12 |
Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 1.31 | |
PBE | C | PowerShares Dynamic Biotech & Genome | 1.24 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 1.11 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.29 | |
VFMO | C | Vanguard U.S. Momentum Factor ETF | 0.24 |
Compare ETFs
- Diabetic Macular Edema
Diabetic retinopathy, also known as diabetic eye disease, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness.Diabetic retinopathy affects up to 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases could be reduced with proper treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is also the leading cause of blindness in people aged 20 to 64.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles